TY - JOUR
T1 - Consumer involvement in the development and dissemination of chronic kidney disease guidelines
T2 - a summary of a meaningful and sustainable approach developed by Caring for Australians and New ZealandeRs with kidney Impairment guidelines
AU - Scholes-Robertson, Nicole
AU - Guha, Chandana
AU - Gutman, Talia
AU - Howell, Martin
AU - Yip, Adela
AU - Cashmore, Brydee
AU - Roberts, Ieyesha
AU - Lopez-Vargas, Pamela
AU - Wong, Germaine
AU - MacGinley, Robert
AU - Synnot, Anneliese
AU - Craig, Jonathan C.
AU - Jauré, Allison
AU - Krishnasamy, Rathika
AU - Tunnicliffe, David J.
AU - the Caring for Australian and New ZealandeRs with Kidney Impairment (CARI) Guidelines Steering Committee
AU - Lee, Vincent
AU - Boag, Jane
AU - Coolican, Helen
AU - Cullen, Vanessa
AU - Fortnum, Debbie
AU - Hassan, Hicham
AU - Jun, Min
AU - Lambert, Kelly
AU - Light, Casey
AU - Nguyen, Thu
AU - Palmer, Suetonia
AU - Scuderi, Carla
AU - See, Emily
AU - Viecelli, Andrea
AU - Walker, Rachael
PY - 2024/6
Y1 - 2024/6
N2 - Objectives: The involvement of consumers (people with lived experience of disease) in guidelines is widely advocated to improve their relevance and uptake. However, the approaches to consumer involvement in guidelines vary and are not well documented. We describe the consumer involvement framework of Caring for Australians and New ZealandeRs with kidney Impairment Guidelines. Study Design and Setting: We used a descriptive document analysis to collate all relevant policies, documents, e-mails, and presentations on consumer involvement in our organizations. We performed a narrative synthesis of collated data to summarize our evolving consumer involvement approach in guidelines. Results: We involve consumers at all levels of Caring for Australians and New ZealandeRs with kidney Impairment guideline development and dissemination according to their capacity, from conducting consumer workshops to inform the scope of guidelines, to including consumers as members of the guideline Working Groups and overseeing operations and governance as members of the Steering Committee and staff. Our approach has resulted in tangible outcomes including high-priority topics on patient education, psychosocial care, and clinical care pathways, and focusing the literature reviews to assess patient-important outcomes. The ongoing partnership with consumers led to the generation of consumer version guidelines to improve guideline dissemination and translation to support shared decision-making. Conclusion: Meaningful consumer involvement can be achieved through a comprehensive approach across the entire lifecycle of guidelines. However, it must be individualized by ensuring that the involvement of consumers is timely and flexible. Future work is needed to assess the impact of consumer involvement in guideline development.
AB - Objectives: The involvement of consumers (people with lived experience of disease) in guidelines is widely advocated to improve their relevance and uptake. However, the approaches to consumer involvement in guidelines vary and are not well documented. We describe the consumer involvement framework of Caring for Australians and New ZealandeRs with kidney Impairment Guidelines. Study Design and Setting: We used a descriptive document analysis to collate all relevant policies, documents, e-mails, and presentations on consumer involvement in our organizations. We performed a narrative synthesis of collated data to summarize our evolving consumer involvement approach in guidelines. Results: We involve consumers at all levels of Caring for Australians and New ZealandeRs with kidney Impairment guideline development and dissemination according to their capacity, from conducting consumer workshops to inform the scope of guidelines, to including consumers as members of the guideline Working Groups and overseeing operations and governance as members of the Steering Committee and staff. Our approach has resulted in tangible outcomes including high-priority topics on patient education, psychosocial care, and clinical care pathways, and focusing the literature reviews to assess patient-important outcomes. The ongoing partnership with consumers led to the generation of consumer version guidelines to improve guideline dissemination and translation to support shared decision-making. Conclusion: Meaningful consumer involvement can be achieved through a comprehensive approach across the entire lifecycle of guidelines. However, it must be individualized by ensuring that the involvement of consumers is timely and flexible. Future work is needed to assess the impact of consumer involvement in guideline development.
KW - Clinical practice guidelines
KW - Consumer involvement
KW - Health communication
KW - Knowledge translation
KW - Patient participation
KW - Shared decision-making
UR - http://www.scopus.com/inward/record.url?scp=85190350247&partnerID=8YFLogxK
UR - http://purl.org/au-research/grants/NHMRC/1092957
U2 - 10.1016/j.jclinepi.2024.111330
DO - 10.1016/j.jclinepi.2024.111330
M3 - Article
C2 - 38537911
AN - SCOPUS:85190350247
SN - 0895-4356
VL - 170
JO - Journal of Clinical Epidemiology
JF - Journal of Clinical Epidemiology
M1 - 111330
ER -